Bariatric Surgery Outcomes in Patients with Inflammatory Bowel Disease: A Single Institution Experience

Matute, Cristian Milla; Fonseca, María; Frieder, Joel S.; Henrique, Juliana; Menzo, Emanuele Lo; Szomstein, Samuel; Rosenthal, Raúl J.

doi:10.1016/j.jamcollsurg.2019.08.1010

Cited by 1 publication

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Based on the inclusion/exclusion criteria, 14 observational studies were finalized for analysis (Figure 1). 11,17‐29 All studies were published after 2013. Of the included studies, nine were published as full manuscripts 11,17‐24 and five were published as abstracts 25‐29 .…”

Section: Resultsmentioning

confidence: 99%

“… 11,17‐29 All studies were published after 2013. Of the included studies, nine were published as full manuscripts 11,17‐24 and five were published as abstracts 25‐29 . One study each originated from the Netherlands 17 and Israel, 22 while the remaining 12 were from United States 11,18‐21,23‐29 .…”

Section: Resultsmentioning

confidence: 99%

“…Nine studies reported data regarding treatment for patients with IBD 11,17,18,20‐23,28,29 . Out of 330 patients, 178 (53.9%) patients were receiving some sort of treatment for their IBD: 33 (13.6%) of 242 patients (six studies) received steroids, 17,18,21‐23,29 126 (40.6%) of 310 patients (eight studies) received immunomodulators/anti‐inflammatory 17,18,20‐23,28,29 and 41 (13.1%) of 314 patients (eight studies) received biologics at the time of surgery 17,18,20‐23,25,29 …”

Section: Resultsmentioning

confidence: 99%

“…Ten studies reported data on the type of bariatric surgery in patients with IBD 11,17,18,20‐25,28 . Of 727 total patients, 342 (47.0%) patients underwent SG, 120 (16.5%) underwent GB, 256 (35.2%) patients underwent RYGB and 9 (1.2%) patients underwent other surgeries.…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Safety of bariatric surgery in patients with inflammatory bowel disease: A systematic review and meta‐analysis

et al. 2020

View full text Add to dashboard Cite

Summary The efficacy of bariatric surgery in achieving weight loss and preventing long‐term comorbidities such as cardiovascular diseases, diabetes mellitus and osteoarthritis is well established. Data regarding safety of bariatric surgery in patients with inflammatory bowel disease (IBD) is scarce. We attempted a systematic review and meta‐analysis to evaluate the complications following bariatric surgery in patients with IBD. The primary outcomes evaluated were wound infection, Clavien‐Dindo grade > II complications and IBD exacerbation (within 1 year). Secondary outcomes evaluated included overall mortality, stricture, small bowel obstruction, acute kidney injury (AKI) and thromboembolism. Pooled outcomes (event rate) with 95% confidence interval (CI) were calculated using random effects model. A total of 14 studies (all observational) with 2608 patients were included. The rates of primary outcomes were: wound infection (4.1%, 95% CI: 0.9‐7.2), Clavien‐Dindo grade > II complications (2.0%, 95%: CI 0.6‐3.5) and IBD exacerbation (4.3%, 95% CI: 0.7‐7.9). The pooled rate for other outcomes was: mortality 0.1%, stricture 6.5%, small bowel obstruction 6.7%, AKI 2.2% and thromboembolism 0.1%. Bariatric surgery is relatively safe in patients with IBD and should be pursued to reduce comorbidities associated with obesity. Future comparative studies are needed to further assess the safety of bariatric surgery in population with and without IBD.

show abstract

Section: Resultsmentioning

confidence: 99%